Cargando…
Phase I clinical studies with cytotoxic drugs: pharmacokinetic and pharmacodynamic considerations.
Autor principal: | Newell, D. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971416/ https://www.ncbi.nlm.nih.gov/pubmed/2178663 |
Ejemplares similares
-
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis
por: Berends, Sophie E., et al.
Publicado: (2018) -
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.
por: Muindi, J. R., et al.
Publicado: (1983) -
A population pharmacokinetic and pharmacokinetic‐pharmacodynamic analysis of vupanorsen from phase I and phase II studies
por: Ahn, Jae Eun, et al.
Publicado: (2023) -
Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein
por: Smith, Sherri A., et al.
Publicado: (2018) -
Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
por: White, Nicholas J.
Publicado: (2013)